Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants

Pediatrics

Volumn 104, Issue 1 I, 1999, Pages 22-27

  Kothadia, Jamanadas M ^a   O'Shea, T Michael ^a   Roberts, Dia ^a   Auringer, Sam T ^a   Weaver III, R Grey ^a   Dillard, Robert G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Dexamethasone; Randomized controlled trials; Very low birth weight

Indexed keywords

DEXAMETHASONE; OXYGEN; PLACEBO;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HIGH RISK PATIENT; HUMAN; LUNG DYSPLASIA; NEWBORN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; VERY LOW BIRTH WEIGHT;

EID: 0032976910     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.1.22     Document Type: Article

References (35)

1. Hack M, Horbar JD, Malloy MH, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics. 1991;87:587-597
2. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985;75:106-111
3. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320:1505-1510
4. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator-and oxygen-dependent infants: a controlled trial. J Pediatr. 1989;115:979-983
5. Kazzi NJ, Brans YW, Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics. 1990;86:722-727
6. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics. 1991;88:421-427
7. Ohlsson A, Calvert SA, Hosking M, Shennan AT. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatr. 1992;81:751-756
8. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics. 1995;95: 584-590
9. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990;117: 273-282
10. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics. 1996;98:204-210
11. Brozanski BS, Jones JG, Gilmour CH, et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr. 1995;126:769-776
12. Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child. 1993;68:566-569
13. Shinwell ES, Karplus M, Zmora E, et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child. 1996;74: F33-F37
14. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994;36: 122-128
15. Sobel DB, Philip AGS. Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics. 1992;90:529-533
16. Batton DG, Roberts C, Trese M, Maisels MJ. Severe retinopathy of prematurity and steroid exposure. Pediatrics. 1992;90:534-536
17. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BW, Dillard RG. Follow-up of preterm infants treated with dexamethasone for chronic lung disease. Am J Dis Child. 1993;147:658-661
18. Ramanathan R, Siassi B, deLemos RA. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. J Perinatol. 1995;15:178-182
19. Kothadia JM, O'Shea TM, Auringer ST, Dillard RG. Response to dexamethasone in ventilated preterm infants: effect of radiographic subtype of chronic lung disease. Am J Perinatol. 1996;13:377-381
20. Bensky AS, Kothadia JM, Covitz W. Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics. 1996;97:818-821
21. Young TE, Mangum OB. Neofax 74 J 94; A Manual of Drugs Used in Neonatal Care. 7th ed. Columbus, OH: Ross Products Division, Abbott Laboratories; 1994:86-87
22. Hyde I, English RE, Williams JD. The changing pattern of chronic lung disease of prematurity. Arch Dis Child. 1989;64:448-451
23. Heneghan MA, Sosulski R, Baquero JM. Persistent pulmonary abnormalities in newborns: the changing picture of bronchopulmonary dysplasia. Pediatr Radiol. 1986;16:180-184
24. Committee on An International Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Pediatrics. 1984;74:127-133
25. Cox DR, Oakes D. Analysis of Survival Data. New York, NY: Chapman and Hall; 1984
26. Proportional Hazards Regression. Cary, NC: SAS Institute
27. Harrell FE, Lee KL. The practical value of logistic regression. In: Proceedings of the Tenth Annual SAS Users Group International Conference; 1985; Cary, NC: SAS Institute. Pages 1031-1036
28. O'Neal EA, Chwals WJ, O'Shea MD, Turner CS. Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child. 1992;67:10-11
29. Ng PC, Brownlee KG, Dear PRF. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child. 1991;66:1164-1166
30. Brownlee KG, Ng PC, Henderson MJ, Smith M, Green JH, Dear PRF. Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child. 1992;67:1-4
31. Gibson AT, Pearse RG, Wales JKH. Growth retardation after dexamethasone administration: assessment by knemometry. Arch Dis Child. 1993; 69:505-509
32. Papile L-A, Tyson JE, Stall BJ, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998;338:1112-1118
33. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101(5). URL: http:// www.pediatrics.org/cgi/content/full/101/5/e7
34. Frank L. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia of who already have developed chronic lung disease: a cautionary note. Pediatrics. 1991;88:413-414
35. Furman L, Hack M, Watts C, Borawski-Clark E, Baley J, Hook B. Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy. J Pediatr. 1995;126:434-440